All | Control | Treatmenta | P valueb | |
---|---|---|---|---|
n (%) | 1.934 (100) | 1.678 (100) | 256 (100) | N/A |
Age (years), mean (SD) | 51 (10) | 50 (10) | 58 (10) | < 0.001 |
Age groups, n (%) | < 0.001 | |||
35 to 44 years | 542 (28) | 520 (31) | 22 (9) | |
45 to 54 years | 713 (37) | 641 (38) | 72 (28) | |
55 to 64 years | 449 (23) | 357 (21) | 92 (36) | |
65 to 74 years | 190 (10) | 133 (8) | 57 (22) | |
≥ 75 years | 40 (2) | 27 (2) | 13 (5) | |
Gender, n (%) | < 0.001 | |||
Men | 916 (47) | 760 (45) | 156 (61) | |
Women | 1018 (53) | 918 (55) | 100 (39) | |
Educational level, n (%) | < 0.001 | |||
Low (≤12 years) | 624 (32) | 498 (30) | 126 (49) | |
High (≥13 years) | 1310 (68) | 1180 (70) | 130 (51) | |
Race, n (%) | ||||
Western-European | 1849 (96) | 1604 (96) | 245 (96) | 0.62 |
Other | 72 (4) | 61 (4) | 11 (4) | |
Cardiovascular historyc, n (%) | 19 (1) | 4 (< 1) | 15 (6) | < 0.001 |
Treatable vascular risk (points)d, mean (SD) | 1 (3) | 1 (3) | 4 (3) | < 0.001 |
Cognitive performance | ||||
RFFT (points), mean (SD) | 74 (26) | 76 (25) | 64 (25) | < 0.001 |
VAT (points), mean (SD) | 10 (2) | 10 (2) | 9 (2) | < 0.001 |
Composite z-scoree, mean (SD) | 0.03 (0.78) | 0.08 (0.77) | −0.30 (0.80) | < 0.001 |